Prescription drug · ANDA
Brinzolamide NDC 68682-464
Brinzolamide 10 mg/mL · Suspension/ drops · Ophthalmic · Oceanside Pharmaceuticals.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68682-464-10 | 6868204641068682046410 | 1 BOTTLE, PLASTIC in 1 CARTON (68682-464-10) / 10 mL in 1 BOTTLE, PLASTICMarketed from Aug 25, 2021 | |
| 68682-464-15 | 6868204641568682046415 | 1 BOTTLE, PLASTIC in 1 CARTON (68682-464-15) / 15 mL in 1 BOTTLE, PLASTICMarketed from Aug 25, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Brinzolamide
- Generic name (nonproprietary)
- brinzolamide
- Active ingredients
- Brinzolamide — 10 mg/mL
- Dosage form
- Suspension/ drops
- Route
- Ophthalmic
- Labeler
- Oceanside Pharmaceuticals.NDC labeler code 68682
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204884
- Marketing start
- Marketing end
- Other FDA classes
- Carbonic Anhydrase Inhibitors (Mechanism)
- Identifiers
- Product ID 68682-464_4fe88efe-d05e-0f99-e063-6294a90a51d3SPL ID 4fe88efe-d05e-0f99-e063-6294a90a51d3SPL set ID fb7229d4-522e-4cb2-b513-9d34f3ded591RxCUI 308805UNII 9451Z89515
- Pharmacologic class
- Carbonic Anhydrase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468682046410followed by a unit qualifier and the quantityPackage 68682-0464-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated for in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 68682-464
- What is NDC 68682-464?
- 68682-464 is the product NDC for Brinzolamide, Brinzolamide 10 mg/mL suspension/ drops, listed with the FDA by Oceanside Pharmaceuticals.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Brinzolamide.
- What is the active ingredient?
- Brinzolamide.
- Who is the labeler?
- Oceanside Pharmaceuticals., NDC labeler code 68682. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Brinzolamide?
- 4 other product NDCs are listed under this name. See all Brinzolamide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Brinzolamide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Brinzolamide | Brinzolamide 10 mg/mL | Suspension/ dropsOphthalmic | Padagis US LLC | 0574-4012 | 00574-4012-1000574-4012-15 |
| Brinzolamide | Brinzolamide 10 mg/mL | Suspension/ dropsOphthalmic | Bryant Ranch Prepack | 72162-2201 | 72162-2201-0272162-2201-04 |
| Brinzolamide | Brinzolamide 10 mg/mL | Suspension/ dropsOphthalmic | Bausch & Lomb Incorporated | 24208-464 | 24208-0464-1024208-0464-15 |
| Brinzolamide | Brinzolamide 10 mg/mL | Suspension/ dropsOphthalmic | Sandoz Inc | 0781-6014 | 00781-6014-7000781-6014-85 |
Other NDCs under ANDA 204884
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Brinzolamide | Brinzolamide 10 mg/mL | Suspension/ dropsOphthalmic | Bausch & Lomb Incorporated | 24208-464 |